spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.


Figure 2


Fig. 2. Regulation of LR Cai2+ levels along the node. Fura-2-loaded embryos were treated with the indicated pharmacological agent or left untreated. The upper panels show a representative Fura-2 image; lower images are the line-scan quantitation of fluorescent intensity versus right-left axis for that embryo, at the position indicated by the yellow line in the upper panel. Images are ventral views with anterior at the top; right (R) and left (L) are as indicated in A; asterisks indicate Hensen's node. (A,B) Untreated embryos at HH5 (A) and HH6 (B). (C) HH6 embryo treated with the intracellular Cai2+ chelator Bapta-AM. (D) HH6 embryo treated with EGTA. (E) HH6 embryo treated with the IP3 antagonist xestospongin C. (F) HH6 embryo treated with the phospholipase C antagonist U73122. (G) HH6 embryo treated with the RyR antagonist 9,21-dehydroryanodine. (H) HH6 embryo treated with the calmodulin antagonist calmidizolium. Some treatments had inconsistent, minor effects on morphology but did not affect the Fura-2 measurements.





Right arrow Return to article